Not logged in Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Monitoring circulating platelet activity to predict cancer-associated thrombosis Li, Bozhao; Lu, Zefang; Yang, Zhenlin; Zhang, Xiuping; Wang, Meiqi; Chu, Tianjiao; Wang, Peina; Qi, Feilong; Anderson, Greg J.; Jiang, Ershuai; Song, Zhenchuan; Nie, Guangjun; Li, Suping Share Save
Nanoparticle-Based Combination Therapy Enhances Fulvestrant Efficacy and Overcomes Tumor Resistance in ER-Positive Breast Cancer Li, Bozhao; Qi, Feilong; Zhu, Fei; Lu, Zefang; Wang, Meiqi; Chu, Tianjiao; Wu, Suying; Wei, Jingyan; Song, Zhenchuan; Sukumar, Saraswati; Zhang, Cheng; Xu, Jiangfei; Li, Suping; Nie, Guangjun Share Save
Nanoparticle-based combination of LMWH and doxorubicin for the efficient treatment of hepatocellular carcinoma with portal vein tumor thrombus Zhang, Xiu-Ping; Li, Bozhao; Lu, Zefang; Hu, Ming-Gen; Zhao, Guo-Dong; Xu, Shuai; Wu, Zhouliang; Chu, Tianjiao; Qi, Feilong; Wu, Suying; Nie, Guangjun; Li, Suping; Liu, Rong Share Save
Identification of protein kinase C beta as a therapeutic target for neuroendocrine prostate cancer and development of a nanoparticle-based therapeutic strategy Qie, Yunkai; Cheng, Zhaoxia; Wu, Zhouliang; Qi, Feilong; Li, Bozhao; Wu, Suying; Chu, Tianjiao; Lu, Zefang; Li, Suping; Nie, Guangjun Share Save
Reducing Postoperative Recurrence of Early-Stage Hepatocellular Carcinoma by a Wound-Targeted Nanodrug Li, Bozhao; Zhang, Xiuping; Wu, Zhouliang; Chu, Tianjiao; Yang, Zhenlin; Xu, Shuai; Wu, Suying; Qie, Yunkai; Lu, Zefang; Qi, Feilong; Hu, Minggen; Zhao, Guodong; Wei, Jingyan; Zhao, Yuliang; Nie, Guangjun; Meng, Huan; Liu, Rong; Li, Suping Share Save
Share Save
Molecularly engineered truncated tissue factor with therapeutic aptamers for tumor-targeted delivery and vascular infarction Li, Bozhao; Wei, Jingyan; Di, Chunzhi; Lu, Zefang; Qi, Feilong; Zhang, Yinlong; Leong, Wei Sun; Li, Lele; Nie, Guangjun; Li, Suping Share Save
Platelet-Membrane-Coated Nanoparticles Enable Vascular Disrupting Agent Combining Anti-Angiogenic Drug for Improved Tumor Vessel Impairment Li, Bozhao; Chu, Tianjiao; Wei, Jingyan; Zhang, Yinlong; Qi, Feilong; Lu, Zefang; Gao, Chao; Zhang, Tianjiao; Jiang, Ershuai; Xu, Junchao; Xu, Jiaqi; Li, Suping; Nie, Guangjun Share Save
Combination of tumour-infarction therapy and chemotherapy via the co-delivery of doxorubicin and thrombin encapsulated in tumour-targeted nanoparticles Li, Suping; Zhang, Yinlong; Ho, Shih-Hsin; Li, Bozhao; Wang, Meifang; Deng, Xiongwei; Yang, Na; Liu, Guangna; Lu, Zefang; Xu, Junchao; Shi, Quanwei; Han, Jing-Yan; Zhang, Lirong; Wu, Yan; Zhao, Yuliang; Nie, Guangjun Share Save
Share Save
Engineered Nanoplatelets for Targeted Delivery of Plasminogen Activators to Reverse Thrombus in Multiple Mouse Thrombosis Models Xu, Junchao; Zhang, Yinlong; Xu, Jiaqi; Liu, Guangna; Di, Chunzhi; Zhao, Xiao; Li, Xiang; Li, Yao; Pang, Ningbo; Yang, Chengzhi; Li, Yanyi; Li, Bozhao; Lu, Zefang; Wang, Meifang; Dai, Kesheng; Yan, Rong; Li, Suping; Nie, Guangjun Share Save
Share Save
The identification of up-regulated ebv-miR-BHRF1-2-5p targeting MALT1 and ebv-miR-BHRF1-3 in the circulation of patients with multiple sclerosis Wang, Y. F.; He, D. D.; Liang, H. W.; Yang, D.; Yue, H.; Zhang, X. M.; Wang, R.; Li, B.; Yang, H. X.; Liu, Y.; Chen, Y.; Duan, Y. X.; Zhang, C. Y.; Chen, X.; Fu, J. Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
